Natco Pharma rises on settling pending litigation with Celgene

23 Dec 2015 Evaluate

Natco Pharma is currently trading at Rs. 575.05, up by 11.40 points or 2.02% from its previous closing of Rs. 563.65 on the BSE.

The scrip opened at Rs. 575.00 and has touched a high and low of Rs. 579.00 and Rs. 568.00 respectively. So far 28,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 598.00 on 26-Nov-2015 and a 52 week low of Rs. 265.98 on 26-Feb-2015.

Last one week high and low of the scrip stood at Rs. 579.00 and Rs. 539.80 respectively. The current market cap of the company is Rs. 10,015.00 crore.

The promoters holding in the company stood at 51.29%, while Institutions and Non-Institutions held 16.74% and 31.97% respectively.

Natco Pharma and its US partner Allergan have settled their pending litigation with Celgene regarding generic Lenalidomide. Celgene has agreed to provide Natco with a license to Celgene’s patents required to manufacture and sell an unlimited quantity of generic Lenalidomide in the United States beginning on January 31, 2026. In addition, Natco will receive a volume-limited license to sell generic Lenalidomide in the United States commencing in March 2022. The volume limit is expected to be a mid-single-digit percentage of the total Lenalidomide capsules dispensed in the United States during the first full year of entry.

The volume limitation is expected to increase gradually each 12 months until March of 2025, and is not expected to exceed one-third of the total Lenalidomide capsules dispensed in the U.S. in the final year of the volume-limited license under this agreement. REVLIMID had recorded sales of nearly $3.4 billion in the US market for the year ending September 2015.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.


Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×